BIEI Financials 07/16/2014 06:44:36
Premier Biomedical Inc
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 217 78 - -
Sales, General and Admin. 4,259 1,603 97 -
Non-Recurring Items - 32 15 -
Other - - - -
Operating Income (4,477) (1,713) (112) -
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax (4,477) (1,713) (112) -
Interest Expense 400 1 - -
Earnings Before Tax (4,877) (1,714) (112) -
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,877) (1,714) (112) -
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,877) (1,714) (112) -
Preferred Stock and Other Adjustments (80) - - -
Net Income Applicable to Common Shareholders (4,957) (1,714) (112) -